Jan 30, 2025
Off-Label Use: Patient Safety Implications
Once authorized, a drug product may be prescribed by a licensed healthcare practitioner for any use deemed appropriate based on the practitioner’s professional opinion. The governing standard is what other similarly trained practitioners would do—not what the manufacturer of the medication or product recommends.
Search
Datos Insights 2025 Impact Award
The Doctors Company, the nation’s largest physician-owned medical malpractice insurer, part of TDC Group, announced today that it has received a 2025 Datos Insights Impact Award for Insurance Innovation. The awards program recognizes organizations that demonstrate excellence in implementing innovative technology solutions that drive measurable business results and industry leadership.
Minor Consent: Challenges for Pediatric Dentistry
Identifying a minor patient’s legal guardianship and parental rights prior to initial treatment can help dental practitioners reduce risk.
Professional Education
Delayed, Wrong, or Missed: Diagnostic Process Failure in Nurse Practitioner Practice
Diagnostic process failure resulting in delayed, wrong, or missed diagnoses has been identified as a serious and often preventable harm in healthcare. To prevent diagnostic error, nurse practitioners (NPs) should be aware of the most misdiagnosed conditions and understand the risks associated with cognitive bias. This course will help NPs understand the 12-step diagnostic process of care framework and determine where contributing factors exist in their primary practice setting to effectively recognize and implement appropriate improvement strategies.
Exclusively Endorsed by the Community Oncology Alliance
The Community Oncology Alliance, Inc. (COA) exclusively endorses The Doctors Company’s medical malpractice insurance program.
Jun 05, 2025
Foundation Receives Record Number of Grant Entries for 2025
In the 2025 grant cycle, The Doctors Company Foundation received a record number of Letters of Intent—107 letters were submitted by the March 19 deadline. The Foundation’s grant review committee will now have the challenging task of evaluating those submissions to select a limited number of projects to move forward to the second phase of the grant making process.
From
The Doctor’s Advocate
Addressing Challenging Patient Situations
Questions about patient relations and patient termination are consistently the top reasons that members request assistance.
Sep 04, 2025
How Inflation Is Impacting Medical Malpractice Claims
Our 2025 study of the impact of inflation on the medical malpractice insurance industry estimates that increasing economic and social inflation added $4 billion in insured losses and expenses incurred by physician-focused insurers. This is a $1.6 billion increase from the previous estimate in our 2023 study. The latest research confirms that inflation is not only persistent—it’s accelerating.
Professional Education
Module 6: Controlled Substance Utilization Review and Evaluation System (CURES) (Innovations and Smart Approaches in Safe Prescribing)
This program reviews the CURES electronic database for Schedule II, III, IV, V controlled substance prescriptions dispensed in California, including time requirements involved when dispensing information needs to be reported (a controlled substance is released to the patient or patient's representative). This module will examine how non-DEA licensed physicians and surgeon practitioners can access CURES data. This module consists of four audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.
Medical Practice Coverages
In today’s healthcare environment, the challenges of running a medical group are complex. The Doctors Company offers consultative, customized, and innovative solutions to reduce and control costs, manage employee benefits, and safeguard your practice.
